Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Feb 19, 2026
  
  First Group Leaders announced for new dedicated Parkinson's Research Centre
  
  In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research...
  Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Our partners
- Partnerships
- Initiatives
- Latest
  
  Jan 01, 2024
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

The Lancet. Neurology

Published Sep 24, 2026

The use of blood biomarkers to understand responses to lecanemab treatment

Authors

Natalie S Ryan

Read More

Abstract

Lancet Neurol. 2026 Sep 24:S1474-4422(26)00359-5. doi: 10.1016/S1474-4422(26)00359-5. Online ahead of print.

NO ABSTRACT

PMID:42785334 | DOI:10.1016/S1474-4422(26)00359-5